Evidence that the 127-164 region of prion proteins has two equi-energetic conformations with β or α features

Biophysical Journal

Volumn 81, Issue 3, 2001, Pages 1657-1665

  Derreumaux, Philippe ^a  

^a UMR 1889 CNRS AVENTIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ARTICLE; CONFORMATIONAL TRANSITION; DISEASE ASSOCIATION; DISEASE TRANSMISSION; ENERGY; ENERGY TRANSFER; NERVE DEGENERATION; NONHUMAN; PROTEIN STRUCTURE; SCRAPIE; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS;

EID: 0034872233     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3495(01)75819-5     Document Type: Article

References (39)

1. Self-assembly of recombinant prion protein of 106 residues
2. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment
3. Specific inhibition of in vitro formation of protein-resistant prion protein by synthetic peptides
4. From polypeptide sequences to structures using Monte Carlo simulations and an optimized potential
5. Generating ensemble averages for small proteins from extended conformations by Monte Carlo simulations
6. Molecular modelling indicates that the pathological conformations of prions might be β-helical
7. Pathways to a protein folding intermediate observed in a I-microsecond simulation in aqueous solution
8. In vivo cytotoxicity of the prion protein fragment 106-126
9. Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: The phenotype of the stop codon 145 mutation in PRNP
10. Fast and simple Monte Carlo algorithm for side chain optimization in proteins
11. A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH
12. Scrapie prions: A three-dimensional model of an infectious fragment
13. Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform
14. Seeding one dimensional crystallization of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?
15. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation
16. Novel missense variants of prion protein in Creutzfeldt-Jacob disease or Gerstmann-Straussler syndrome
17. Application of a self-consistent mean field theory to predict protein side-chains conformation and estimate their conformational entropy
18. Sc)-specific epitope defined by a monoclonal antibody
19. Discrimination of the native from misfolded protein models with an energy function including implicit solvation
20. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein
21. Peptides and proteins in neurodegenerative disease: Helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy
22. The role of disulfide bridge in the folding and stability of the recombinant human prion protein
23. Equation of state calculations by fast computing machines
24. C helix 1 in the hydrophilic seeding of prion aggregates
25. Molecular dynamics of mouse and Syrian hamster PrP: Implications for activity
26. A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform
27. Prion diseases and the BSE crisis
28. NMR structure of the mouse prion protein domain PrP(121-231)
29. Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126
30. Prion protein fragments spanning helix 1 and both strands of beta sheet (residues 125-170) show evidence for predominantly helical propensity by CD and NMR
31. Automated analysis of interatomic contacts in proteins
32. Reversion of prion protein conformational changes by synthetic β-sheet breaker peptides
33. +] factor by in vitro-converted sup35 protein
34. Prion protein of 106 residues creates an artificial transmission barrier for prion replication in transgenic mice
35. Gerstmann-Straussler-Scheinker disease with mutation at codon 102 and methionine at codon 129 of PRNP in previously unreported patients
36. NMR solution structure of the human prion protein
37. Conformational transitions in peptides containing two putative α-helices of the prion protein
38. Solution structure of the E200K variant of human prion protein